🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
RBC Bioscience Corporation (TPEX:6848)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
18.60
-1.45 (-7.23%)
Nov 20, 2026, 1:48 PM CST

RBC Bioscience Cash Flow Statement

Millions TWD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
15.3123.5421.576.433.7828.73
Depreciation & Amortization
15.915.4717.5418.7519.2819.45
Other Amortization
1.171.170.550.450.460.41
Loss (Gain) From Sale of Assets
---00.02-0.010.54
Asset Writedown & Restructuring Costs
-----0.93
Provision & Write-off of Bad Debts
0.030.080.420.11-0.1-0.37
Other Operating Activities
0.630.513.43-7.151.3-28.74
Change in Accounts Receivable
8.43-12.89.092.48-0.8127.54
Change in Inventory
-6.035.27-8.342.7849.59
Change in Accounts Payable
5.990.38.05-6.99-13.04-65.31
Change in Unearned Revenue
1.50.130.790.06-1.111.06
Change in Other Net Operating Assets
0.516.842.83-3.73-7.14-19.11
Operating Cash Flow
43.4340.5255.9313.216.6-25.3
Operating Cash Flow Growth
10.00%-27.55%323.45%100.03%--

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-1.04-6.44-2.13-4.99-9.96-449.72
Sale of Property, Plant & Equipment
--0-0.010.01
Sale (Purchase) of Intangibles
-0.17-6.67-8.19-1.47-0.09-0.39
Other Investing Activities
-1.71-2.320.957.4722.6524.44
Investing Cash Flow
-0.89-15.43-9.37112.61-425.67

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
--35203.46-404.06
Total Debt Issued
61-35203.46-404.06
Short-Term Debt Repaid
--25-10-5-24.65-6.35
Long-Term Debt Repaid
--39.23-43.9-208.89-4.59-8.84
Lease Payments
-1.39-1.22-1.27-1.46-1.98-6.81
Total Debt Repaid
-64.94-64.23-53.9-213.89-29.24-15.19
Net Debt Issued (Repaid)
-3.94-64.23-18.9-10.43-29.24388.87
Issuance of Common Stock
-----50
Common Dividends Paid
-71.86-4.28-12.98-14.53-11.8-14.38
Other Financing Activities
----0.29-
Financing Cash Flow
-75.8-68.52-31.88-24.96-40.75424.49

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-33.25-43.4214.68-10.75-21.54-26.48

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
42.434.0853.88.21-3.36-475.02
Free Cash Flow Growth
30.68%-36.64%554.94%---
Free Cash Flow Margin
20.23%15.51%26.21%4.76%-1.93%-189.12%
Free Cash Flow Per Share
2.952.373.750.57-0.23-35.11
Levered Free Cash Flow
51.2316.838.362.9519.92-460.85
Unlevered Free Cash Flow
56.8122.8644.819.224.66-456.89
Free Cash Flow After Leases
41.0132.8752.536.75-5.33-481.83

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
9.759.7510.2710.087.415.94
Cash Income Tax Paid
5.695.6928.55036.35
Change in Working Capital
10.39-0.2512.43-5.4-18.11-46.24